BlueCrest Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-10,843
Closed -$532K – 1209
2018
Q4
$532K Sell
10,843
-63,074
-85% -$3.59M 0.03% 335
2018
Q3
$4.58M Sell
73,917
-63,704
-46% -$3.87M 0.12% 116
2018
Q2
$7.41M Buy
137,621
+116,130
+540% +$5.8M 0.19% 109
2018
Q1
$977K Buy
+21,491
New +$921K 0.03% 490
2017
Q4
– Sell
-6,065
Closed -$224K – 891
2017
Q3
$224K Buy
+6,065
New +$216K 0.01% 725
2015
Q1
– Sell
-15,713
Closed -$481K – 646
2014
Q4
$481K Buy
+15,713
New +$490K 0.02% 450

Other funds holding EHC

BlueCrest Capital Management's EHC Position: Q1 2019 in Review

BlueCrest Capital Management sold out of Encompass Health (EHC) in Q1 2019, closing a stake of 10,843 shares — an estimated $532K sold.

BlueCrest Capital Management first reported a position in EHC in Q4 2014 and held it in 6 quarters. The position peaked at $7.41M in Q2 2018. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

  • BlueCrest Capital Management reported no remaining Encompass Health position as of Q1 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 10,843 Encompass Health shares in Q1 2019, an estimated $532K.
  • BlueCrest Capital Management first reported a position in Encompass Health in Q4 2014 and held it in 6 quarters.
  • BlueCrest Capital Management's Encompass Health position peaked at $7.41M in Q2 2018.
  • 427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.